BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 21671892)

  • 21. Non-corticosteroid adherence and itch severity influence perception of itch in atopic dermatitis.
    Takeuchi S; Oba J; Esaki H; Furue M
    J Dermatol; 2018 Feb; 45(2):158-164. PubMed ID: 29168215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poor compliance with topical corticosteroids for atopic dermatitis despite severe disease.
    Brown KL; Krejci-Manwaring J; Tusa MG; Camacho F; Fleischer AB; Balkrishnan R; Feldman SR
    Dermatol Online J; 2008 Sep; 14(9):13. PubMed ID: 19061595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial.
    Leung DY; Hanifin JM; Pariser DM; Barber KA; Langley RG; Schlievert PM; Abrams B; Hultsch T
    Br J Dermatol; 2009 Aug; 161(2):435-43. PubMed ID: 19416245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic acid emollient foam in the treatment of patients with atopic dermatitis.
    Frankel A; Sohn A; Patel RV; Lebwohl M
    J Drugs Dermatol; 2011 Jun; 10(6):666-72. PubMed ID: 21637908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical Corticosteroid Concerns Among Parents of Children with Psoriasis versus Atopic Dermatitis: A French Multicenter Cross-Sectional Study.
    Moawad S; Mahé E; Aubert-Wastiaux H; Phan A; Maruani A; Chiaverini C; Bodemer C; Mazereeuw-Hautier J; Lasek-Duriez A; Droitcourt C; Barbarot S; Beauchet A; Bursztejn AC;
    Am J Clin Dermatol; 2018 Apr; 19(2):261-265. PubMed ID: 28849428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety considerations in topical treatments for atopic dermatitis.
    Nicol NH
    Pediatr Nurs; 2011; 37(6):295-301; quiz 302. PubMed ID: 22256690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical therapy in pediatric atopic dermatitis.
    Krakowski AC; Dohil MA
    Semin Cutan Med Surg; 2008 Jun; 27(2):161-7. PubMed ID: 18620139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atopic dermatitis in children in the United States, 1997-2004: visit trends, patient and provider characteristics, and prescribing patterns.
    Horii KA; Simon SD; Liu DY; Sharma V
    Pediatrics; 2007 Sep; 120(3):e527-34. PubMed ID: 17766497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical corticosteroid phobia in atopic dermatitis: International feasibility study of the TOPICOP score.
    Stalder JF; Aubert H; Anthoine E; Futamura M; Marcoux D; Morren MA; Trzeciak M; Szalai Z; Veres K; Deleuran M; Vestergaard C; Boralevi F; Chu CY; De Raeve L; Svensson Å; Fölster-Holst R; Buchner M; Takaoka R; Aoki V; Chernyshov P; Chernyshova L; Murrell DF; Zhao C; Mckinster CD; Von Kobyletzky L; Eichenfield L; Totri C; Lio P; Seneschal J; Moret L; Barbarot S
    Allergy; 2017 Nov; 72(11):1713-1719. PubMed ID: 28439896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of socioeconomic status of Japanese patients with atopic dermatitis showing poor medical adherence and reasons for drug discontinuation.
    Murota H; Takeuchi S; Sugaya M; Tanioka M; Onozuka D; Hagihara A; Saeki H; Imafuku S; Abe M; Shintani Y; Kaneko S; Masuda K; Hiragun T; Inomata N; Kitami Y; Tsunemi Y; Abe S; Kobayashi M; Morisky DE; Furue M; Katoh N
    J Dermatol Sci; 2015 Sep; 79(3):279-87. PubMed ID: 26255207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticosteroid phobia (corticophobia) in parents of young children with atopic dermatitis and their health care providers.
    Bos B; Antonescu I; Osinga H; Veenje S; de Jong K; de Vries TW
    Pediatr Dermatol; 2019 Jan; 36(1):100-104. PubMed ID: 30338542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of topical calcineurin inhibitors in atopic dermatitis.
    Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
    Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of early intervention with pimecrolimus cream 1% combined with corticosteroids for major flares in infants and children with atopic dermatitis.
    Siegfried E; Korman N; Molina C; Kianifard F; Abrams K
    J Dermatolog Treat; 2006; 17(3):143-50. PubMed ID: 16854753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corticosteroid phobia and other confounders in the treatment of childhood atopic dermatitis explored using parent focus groups.
    Smith SD; Hong E; Fearns S; Blaszczynski A; Fischer G
    Australas J Dermatol; 2010 Aug; 51(3):168-74. PubMed ID: 20695854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Focus group parental opinions regarding treatment with topical corticosteroids on children with atopic dermatitis.
    Veenje S; Osinga H; Antonescu I; Bos B; de Vries TW
    Allergol Immunopathol (Madr); 2019; 47(2):166-171. PubMed ID: 30316560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of skin concentrations following topical versus oral corticosteroid treatment: reconsidering the treatment of common inflammatory dermatoses.
    McClain RW; Yentzer BA; Feldman SR
    J Drugs Dermatol; 2009 Dec; 8(12):1076-9. PubMed ID: 20027934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TOPICOP©: a new scale evaluating topical corticosteroid phobia among atopic dermatitis outpatients and their parents.
    Moret L; Anthoine E; Aubert-Wastiaux H; Le Rhun A; Leux C; Mazereeuw-Hautier J; Stalder JF; Barbarot S
    PLoS One; 2013; 8(10):e76493. PubMed ID: 24146878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spotlight on topical pimecrolimus in pediatric atopic dermatitis.
    Yang LP; Curran MP
    Am J Clin Dermatol; 2010; 11(4):295-8. PubMed ID: 20509720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
    Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
    Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema.
    Zoller L; Ramon M; Bergman R
    Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.